N.Y. Health Information Network harnesses MedLink, Thrasys systems

MedLink, in collaboration with Thrasys, have formed the New York Health Information Network (NYHIN), a regional health information network that falls under the Connected Healthcare initiative launched by the two companies earlier this year.

Connected Healthcare and regional health information networks will enable physicians, patients, service centers and health plans to coordinate care, manage costs, increase revenues, improve outcomes and enhance patient experience, MedLink stated.

NYHIN will provide interoperability, applications and services using Thrasys’ cloud-based SyntraNet connected healthcare platform, which provides an open foundation for collaborative healthcare networks.

NYHIN will implement a health information exchange (HIE), enabling providers to meet interoperability requirements for meaningful use, and deliver applications and services including EHRs, practice management services, e-prescribing, group purchasing, insurance and eligibility verification, remote charge capture, physician quality reporting, patient portals, and services to enable accountable care organizations and patient-centered medical homes.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.